Real‐world data on eslicarbazepine acetate as add‐on to antiepileptic monotherapy

OBJECTIVE: To assess retention, tolerability, and safety, efficacy and effects on quality of life (QoL) of eslicarbazepine acetate (ESL) add‐on treatment over 6 months in a real‐world adult population with partial‐onset seizures. METHODS: This non‐interventional, multicenter, prospective study was p...

Descripción completa

Detalles Bibliográficos
Autores principales: Holtkamp, M., McMurray, R., Bagul, M., Sousa, R., Kockelmann, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067651/
https://www.ncbi.nlm.nih.gov/pubmed/26915469
http://dx.doi.org/10.1111/ane.12574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067651/
https://www.ncbi.nlm.nih.gov/pubmed/26915469
http://dx.doi.org/10.1111/ane.12574

Ejemplares similares